Skip to content

Study to Evaluate the Impact of the PROactive Telecoaching Program on Physical Activity in Patients With COPD.

A 6-month Multicenter Randomized Trial to Evaluate the Impact of the PROactive Telecoaching Program on Physical Activity in Patients With COPD

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01992081
Acronym
PROactive
Enrollment
0
Registered
2013-11-25
Start date
2014-05-31
Completion date
2015-06-30
Last updated
2017-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COPD

Keywords

COPD, Physical Activity, Telecoaching, PROactive

Brief summary

This study will test two instruments to measure physical activity in COPD patients: A questionnaire and two small physical activity monitors .Patients will be randomized to either receive the telecoaching program in addition to usual care or only the usual care. Study will include around 510 patients in 5 countries in Europe.

Detailed description

Chronic Obstructive Pulmonary Disease (COPD) has a negative influence on physical activity hence it may be beneficial for patients to increase physical activity levels. This study will test two instruments to measure physical activity: A questionnaire (completed on a personal digital assistant) and a physical activity monitor which patient wear during the day. Patients will be randomized to either receive the Telecoaching program in addition to usual care or only the usual care. The study will involve 4 clinic visits as well as some phone calls over duration of 6 months.

Interventions

DEVICEAutomated telehealth system

The automated telehealth system (used within its intended use) comprises of CE marked medical devices and a CE marked step counter (Fitbug®), all being used within their intended use. Coaching by investigators is performed during the study visits and is aimed to enhance physical activity in patients across a spectrum of COPD severity, in addition to the usual care.

OTHERUsual care

Participants will receive usual care associated with Chronic Obstructive Pulmonary Disease (COPD)

Sponsors

Innovative Medicines Initiative
CollaboratorOTHER
Novartis Pharmaceuticals
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Written informed consent * Male and female patients ≥ 40 years of age * Diagnosis of COPD (GOLD criterion: post bronchodilator FEV1/FVC\< 70%) * Current or ex-smokers with a smoking history equivalent to at least 10 pack years (1 pack year = 20 cigarettes smoked per day for 1 year) * Patients should have at least 4 days of physical activity data recorded via activity monitor during 7 days prior to visit 101.

Exclusion criteria

Patients fulfilling any of the following criteria are not eligible for inclusion in this study. * Orthopedic, neurological or other complaints that significantly impair normal biomechanical movement patterns, as judged by the investigator. Specifically if the patients' condition/ co-morbidities are such that physical activity cannot be increased. * Respiratory diseases other than COPD (e.g. asthma) * Cognitive reading impairment and/or difficulties to manage electronic devices precluding interaction with the health base and PDA, as judged by the investigator * Participating in or scheduled to start a rehabilitation program during the study. If the patient wishes to participate in pulmonary rehabilitation for any reason the patient can be enrolled in the study only at the end of rehabilitation. * Women of child-bearing potential who have the intention to become pregnant during the course of the study and pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation, confirmed by a positive β-hCG laboratory test.

Design outcomes

Primary

MeasureTime frameDescription
The impact of telecoaching program on the physical activity6 monthsImpact of telecoaching program on the physical activity of COPD patients will be measured via the use of two PROactive monitors (ActiGraph® and DynaPort®) and a PDA to complete the PROactive questionnaire.
The construct validity of the PROactive instrument.6 monthsConstruct validity of the PROactive instrument will be measured via the use of two PROactive monitors (ActiGraph® and DynaPort®) and a PDA to complete the PROactive questionnaire.
The responsiveness of the PROactive instrument.6 monthsResponsiveness of the PROactive instrument will be measured via the use of two PROactive monitors (ActiGraph® and DynaPort®) and a PDA to complete the PROactive questionnaire.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026